微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 39.27% | -21.23% | -3.93% | 103/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 40.87% | -22.39% | -1.46% | 96/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 41.48% | -23.28% | -12.21% | 92/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 47.25% | 15.43% | -5.22% | 85/160 | 51.38% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 49.86% | 2% | -5.34% | 79/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 52.67% | 29.42% | -2.59% | 73/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 54.07% | 2% | 32.08% | 70/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 40.94% | -2.77% | 0.59% | 102/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
| 2022-06-30 | 40.7% | -8.17% | -3.34% | 97/160 | 21.79% | 迈威生物 | 99.67% | 行业排名> |
| 2021-12-31 | 42.1% | -15.89% | -5% | 96/160 | 55.07% | 迈威生物 | 99.44% | 行业排名> |
| 2021-06-30 | 44.32% | -2.23% | -11.47% | 86/160 | 47.45% | 迈威生物 | 98.57% | 行业排名> |
| 2020-12-31 | 50.06% | 10.02% | 10.02% | 81/160 | -143.08% | 首药控股 | 99.93% | 行业排名> |
| 2019-12-31 | 45.5% | 23.4% | 0.38% | 89/160 | -1204.25% | 艾力斯 | 99.41% | 行业排名> |
| 2019-06-30 | 45.33% | 43.09% | 22.93% | 71/160 | 55.36% | 艾力斯 | 98.7% | 行业排名> |
| 2018-12-31 | 36.87% | 2% | 16.39% | 102/160 | -205.91% | 艾力斯 | 99.4% | 行业排名> |
| 2018-06-30 | 31.68% | 2% | 2% | 89/160 | 53.68% | 首药控股 | 99.94% | 行业排名> |